Wolverine Trading
ALDX icon

Wolverine Trading’s Aldeyra Therapeutics ALDX Stock Holding History

Wolverine Trading’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,100
Closed -$36.3K – 4407
2024
Q1 		$36.3K Buy
+11,100
New +$36.5K ﹤0.01% 4273
2023
Q3 		– Sell
-36,900
Closed -$292K – 4427
2023
Q2 		$292K Buy
36,900
+9,200
+33% +$90.6K ﹤0.01% 3124
2023
Q1 		$263K Buy
27,700
+12,000
+76% +$84.8K ﹤0.01% 3153
2022
Q4 		$109K Buy
15,700
+4,700
+43% +$26.9K ﹤0.01% 3381
2022
Q3 		$58K Buy
+11,000
New +$66K ﹤0.01% 4102

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Wolverine Trading's ALDX Position: Q2 2025 in Review

Wolverine Trading sold out of Aldeyra Therapeutics (ALDX) in Q2 2025, closing a stake of 12,028 shares — an estimated $31.1K sold.

Wolverine Trading first reported a position in ALDX in Q2 2022 and held it in 5 quarters. The position peaked at $209K in Q1 2023. 121 funds tracked by Wall St. Rank hold ALDX as of Q2 2025.

  • Wolverine Trading reported no remaining Aldeyra Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 12,028 Aldeyra Therapeutics shares in Q2 2025, an estimated $31.1K.
  • Wolverine Trading first reported a position in Aldeyra Therapeutics in Q2 2022 and held it in 5 quarters.
  • Wolverine Trading's Aldeyra Therapeutics position peaked at $209K in Q1 2023.
  • 121 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.